Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine.

Post date April 27, 2022 — 13:16 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

Oxycon (002913): Announcement on the progress of Oxycon Technology Co., Ltd. on the use of some idle self-owned funds for cash management- CFi.CN Zhongcai Network

May 20, 2022 — 17:56

Runyang Technology: The company's research and development projects are mainly the research and development of high-strength IXPE foam materials, the research and development of thermally conductive and insulating polyethylene foam materials, and the research and development of radiation cross-linked polybutylene succinate foam materials, etc.

May 20, 2022 — 17:55

Meichen Ecology: The company has not verified the effect of CBD on preventing new crown infection

May 20, 2022 — 17:50

Jinlei shares: the company has been in a state of full production in the first quarter and April, and the capacity utilization rate is close to saturation

May 20, 2022 — 17:49

Palm Shares: The company has no ties to Dukang Liquor

May 20, 2022 — 17:40

Eating duck neck and drinking milk tea directly to Juewei Food's annual shareholders meeting is really "fragrant" scene

May 20, 2022 — 17:00

Luxshare Precision has been surveyed by 5 institutions: at this stage, what the company is doing is to rapidly integrate existing products, and accelerate the development of products that do not (with survey questions and answers)

May 20, 2022 — 16:00

The annual report of Shuanghui Development was asked about an increase of 115% in daily related transactions last year compared with 2017

May 17, 2022 — 16:15

The annual report of Shuanghui Development was asked about an increase of 115% in daily related transactions last year compared with 2017

May 17, 2022 — 16:15

Home » News » Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine.